| My Account | Subscribe | Contact Us | Donate |
Home
- The Edmonton Protocol and Me
- Olympia Dukakis and Her Husband Tackle Type 2
- Surfing with Type 1
- Behind the Wheel, But Still in Control
You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
If you are a physician, educator and medical professional who focus on the treatment of diabetes, then this is the must have resource for you.
Finally! A fresh take on the “professional” journal. Each bi-monthly issue cuts through the jargon and presents the most important information you need to enhance your practice and assist your patients.
Each bi-monthly issue of Diabetes Health Professional is a self-contained handbook covering products, educational resources and the latest diabetes research, complimented by balanced editorial focused on medical news, drug prescription information, clinical practice recommendations and changing treatment options.
Each quarter we send you the latest, most updated research guides, product guides and educational resource guides available for you and your patients.
Each week the Diabetes Health E-Newsletter delivers links to the very latest in news, reviews, blogs and videos from Diabetes Health direct to your inbox.
As a subscriber you'll get access to the amazing Diabetes Health Digital Advantage™ so you can read the current issue of Diabetes Health magazine online wherever you are!
You can cancel your newsletter subscription at anytime by clicking "Unsubscribe" on the bottom of any newsletter you receive
Then enter your new email address in the above form and click "Subscribe"
Latest Medications Articles
Researchers believe that immunosuppressants may have an effect on how long transplanted islet cells can function before losing their effectiveness.
Type 1s Live Insulin-Free For Up to Two Years, Thanks to Transplanted Human Islet Cells... But There's a Catch
HealthDay reports that according to a University of Miami study, people with type 1 diabetes who received transplanted islet cells from human donors lived insulin-free for up to two years.
The bad news is that the patients must take immunosuppressant drugs for the rest of their lives, even as the functionality of the transplanted cells almost totally declines.
The good news is that even after the patients resume using insulin, their metabolic control tends to be better than before the transplants.
The study, by the University of Miami’s Miller School of Medicine, used continuous glucose monitoring to track blood glucose levels in 25 patients, 12 of whom received islet cell transplants and 13 of whom acted as study controls.
Candidates for the study were type 1s who had experienced poor blood sugar control and severe recurrent hypoglycemic episodes.
After the transplants, patients stayed insulin-free for an average of 18 months. Forty percent of the study’s subjects were insulin-free at 24 months. Their A1c levels improved dramatically, from an average of 7.6% before transplantation to 5.5% within 90 days afterward.
When the effect of the transplants wore off, patients who had to return to taking insulin used significantly less than before and had considerably fewer episodes of hypoglycemia.
Researchers believe that immunosuppressants may have an effect on how long transplanted islet cells can function before losing their effectiveness. If so, the search is on for drugs with a much less drastic effect.
Categories: Hospital Care, Medications, Type 1 Issues
Facebook
MySpace 
Digg
You May Also Be Interested In...
Click Here To View Or Post Comments
May 30, 2008 -
Email to a Friend
Send a link to this page to your friends and colleagues.